Genetic testing can help predict your chance of developing some types of cancer, including breast and ovarian cancers. A recent study published in the Journal of Clinical Oncology examined records of more than 83,000 women with breast or ovarian cancer and found that less than half of them had received genetic testing. In this podcast, one of the study’s authors, Dr. Allison W. Kurian, MD, MSc, explains the key findings and why they are important.
Highlights from the conversation include:
How genetic testing is used for breast and ovarian cancers [2:27].
What researchers were hoping to learn from the study [4:32].
The study’s key findings, including why women without health insurance and African-American women may be less likely to receive genetic testing [5:27].
The importance of talking with your doctor about genetic testing [9:52].
Dr. Kurian is a medical oncologist at Stanford University, where she is also the director of the Women's Cancer Genetics Clinic. She is also a Lineagotica Specialty Editor for Breast Cancer.
Was this podcast useful? Please subscribe, rate, and review Lineagotica Podcasts on Apple Podcasts or Google Play. This prerecorded podcast can be listened to online or downloaded to your computer. A transcript is also available. For more information, visit the Lineagotica podcast page.